Financial News
Nano Hearing Aids Announces CEO Ryan F. Zackon Awarded Esteemed UAE Golden Visa
Leading provider of over the counter (OTC) hearing aids Nano Hearing Aids (888-310-NANO) announces that CEO Ryan F. Zackon has been awarded the prestigious UAE Golden Visa.
Coppell, United States - November 25, 2024 —
This esteemed award will enable the company’s expansion into the Middle East and GCC regions to deliver accessible hearing aid solutions to millions of adults 18+ coping with perceived mild to moderate hearing loss. Awarded in November 2024, this achievement highlights Nano Hearing Aids’ commitment to innovation and improved access to affordable hearing solutions globally.
To access the full announcement, visit https://nanohearingaids.com/blogs/in-the-news/ryan-f-zackon-ceo-of-nano-hearing-aids-awarded-prestigious-uae-golden-visa
The UAE Golden Visa is a distinguished long-term residency and business permit granted to leaders, investors, and innovators demonstrating excellence in their respective fields. Introduced in 2019 to attract global talent and foster innovation, the visa is a symbol of impactful contributions across sectors like technology to healthcare.
“I am honored to receive the UAE Golden Visa and deeply grateful to HH Sheikh Mohammed Bin Rashid Al Maktoum for this recognition,” says Zackon. “This milestone is not just a personal achievement, but a reflection of the incredible work being done by the entire team at Nano Hearing Aids. We are committed to making hearing care more accessible and affordable, and this opportunity will further support our mission to improve lives around the world.”
The OTC hearing aid market in the Middle East and North Africa region is still emerging. While traditional hearing aids are available, the adoption of OTC devices is limited compared to regions like North America and Europe.
Direct-from-manufacturer OTC hearing aids will enable adults in this region with perceived mild to moderate hearing loss to access the devices they need to increase sound levels, similar to prescription devices, but without a visit to the audiologist. Compared to prescription hearing aids that can cost between US$2,000 and $6,000, Nano’s latest devices, Completely in Canal (CIC) hearing aids, introduced in September 2024, start at just US$297.
Nearly invisible and designed to sit comfortably and deeply inside the ear canal, Nano’s advanced OTC CIC devices are available in two- and four-program formats. Compact, rechargeable, and user-friendly, the First Ear Pro and First Ear Plus CICs, alongside a range of BTE and RIC models, offer adults and seniors a variety of innovative, discreet, and affordable hearing solutions designed to meet a broad range of needs and aimed at improving their overall quality of life.
The UAE’s progressive focus on healthcare innovation and global talent development makes it an ideal base for Nano Hearing Aids to deliver transformative hearing solutions to new markets worldwide.
Learn more at https://nanohearingaids.com
Contact Info:
Name: Media Inquiries
Email: Send Email
Organization: Hearing At Home LLC
Address: 511 South Royal Lane, Coppell, TX 75019, United States
Phone: +1-404-822-3309
Website: https://hearingathome.com/
Source: PressCable
Release ID: 89147054
Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.